Evidence map›Paper›PMID 38339146›Full record

ArticleInternational journal of molecular sciences2024

Protective Effect of the Novel Melatonin Analogue Containing Donepezil Fragment on Memory Impairment via MT/ERK/CREB Signaling in the Hippocampus in a Rat Model of Pinealectomy and Subsequent Aβ

Jana Tchekalarova, Petya Ivanova, Desislava Krushovlieva, Lidia Kortenska, Violina T Angelova

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. International journal of molecular sciences · 2026
    Article
  2. Pinealectomy-Induced Neuroinflammation Varies with Age in Rats.International journal of molecular sciences · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jana TchekalarovaInstitute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.ORCID 0000-0003-1640-5099
Petya IvanovaInstitute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Desislava KrushovlievaInstitute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Lidia KortenskaInstitute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Violina T AngelovaDepartment of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.ORCID 0000-0002-6415-7336
Bulgarian Academy of Sciences · BGMedical University of Sofia · BG

Funding

Bulgarian National Science Fund KP-06-N63/11; 14.12.2022
6 · The paper itself

Abstract

A reduction in melatonin function contributes to the acceleration of Alzheimer's disease (AD), and understanding the molecular processes of melatonin-related signaling is critical for intervention in AD progression. Recently, we synthesized a series of melatonin analogues with donepezil fragments and tested them in silico and in vitro. In this study, one of the most potent compounds,

Indexed as

Alzheimer DiseaseMelatoninPeptide FragmentsAmyloid beta-PeptidesAnimalsDonepezilHippocampusMemory DisordersPinealectomyRatsAmyloid beta-Peptidesamyloid beta-protein (1-42)DonepezilMelatoninPeptide FragmentsAlzheimer’s diseaseCREBERKicvAβ1-42melatoninmelatonin analogueMT receptorspTAU

Identifiers

PMID38339146
PMCPMC10855364
OpenAlexW4391533344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.